1. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
   Paola Anna Jablonska et al, 2019, PLOS ONE CrossRef
2. Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience
   Amal Rayan et al, 2020, Reports of Practical Oncology & Radiotherapy CrossRef
3. Improved Diagnostic Imaging of Brain Tumors by Multimodal Microscopy and Deep Learning
   Johanna Gesperger et al, 2020, Cancers CrossRef
4. Imaging-Based Patterns of Failure following Re-Irradiation for Recurrent/Progressive High-Grade Glioma
   Debanjali Datta et al, 2023, Journal of Personalized Medicine CrossRef
5. Efficacy and Safety of Intraoperative Radiotherapy for High-Grade Gliomas: A Systematic Review and Meta-Analysis
   Lucca B. Palavani et al, 2024, Neurosurgical Review CrossRef
6. Repeated surgical resections for management of high-grade glioma and its impact on quality of life
   Jun Min Koay et al, 2024, Journal of Neuro-Oncology CrossRef
7. Up‐regulation of plakophilin‐2 is correlated with the progression of glioma
   Degeng Zhang et al, 2017, Neuropathology CrossRef
8. Observation of the delineation of the target volume of radiotherapy in adult-type diffuse gliomas after temozolomide-based chemoradiotherapy: analysis of recurrence patterns and predictive factors
   Hongbo Liu et al, 2023, Radiation Oncology CrossRef
9. Residual Disease in Glioma Recurrence: A Dangerous Liaison with Senescence
   Diana A. Putavet et al, 2021, Cancers CrossRef
10. Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival
    Akshitkumar M Mistry et al, 2019, Neurosurgery CrossRef
11. Oncolytic virotherapies for pediatric tumors
    Evan G Gross et al, 2023, Expert Opinion on Biological Therapy CrossRef
12. Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
    Tugce Kutuk et al, 2022, Cancers CrossRef
13. Neuroimaging classification of progression patterns in glioblastoma: a systematic review
    Rory J. Piper et al, 2018, Journal of Neuro-Oncology CrossRef
14. A machine learning‐based survival prediction model of high grade glioma by integration of clinical and dose‐volume histogram parameters
    Haiyan Chen et al, 2021, Cancer Medicine CrossRef
15. Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas
    Razvan Onciul et al, 2024, Current Issues in Molecular Biology CrossRef
16. Photodynamic therapy using talaporfin sodium for non-totally resectable malignant glioma
    Shinjiro Fukami et al, 2024, Photodiagnosis and Photodynamic Therapy CrossRef
17. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells
    Yingge Wang et al, 2016, Molecular Medicine Reports CrossRef
18. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
    Peng Chen et al, 2020, Bioscience Reports CrossRef
19. The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
    Lin Zheng et al, 2021, Frontiers in Oncology CrossRef
20. Cancer Dissemination, Hydrocephalus, and Survival After Cerebral Ventricular Entry During High-Grade Glioma Surgery
    Akshitkumar M Mistry et al, 2018, Neurosurgery CrossRef
21. Magnetic resonance imaging evaluation of brain glioma before postoperative radiotherapy
    Z. Sui et al, 2021, Clinical and Translational Oncology CrossRef